Skip to main content

Table 4 Cell cycle distribution of HepG2 cells after treatment with or without RES for 48 h

From: Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model

  Cell cycle distribution
  Res (μM)
Cell groups DMSO 20 50 100 200
  G1 G2 S G1 G2 S G1 G2 S G1 G2 S G1 G2 S
HepG2 76.3 9.6 14.1 73.0 13.5 13.5 25.3 4.8 69.9* 34.9 7.4 57.7* 72.7* 8.8 18.5
CAV1 57.9 10.0 32.1 15.4 7.5 77.1* 27.5 21.4 51.1* 65.8* 1.6 32.6 73.5* 24.2 2.3
CAVM1 58.9 16.0 25.0 69.5 8.9 21.6 33.9 10.5 55.7* 39.9 20.0 40.1* 79* 8.6 12.4
CAVM2 68.2 11.1 20.7 72.5 3.8 23.7 30.5 8.4 61.1* 75.8* 3.1 21.1 74.1* 8.5 17.4
CAVRNAi 57.8 10.2 38.1 45.3 16.4 32.3 37.5 21.1 55.0* 64.9* 19.5 15.7 69.2* 13.1 17.7
GFP 77.4 5.9 16.7 73.2 14.0 12.5 22.3 6.0 71.7* 30.4 7.8 61.8* 70.0* 10.5 20.5
  1. *P < 0.05 vs control, [ ± SD, SD = (0.8~3.7), n = 3]